<DOC>
	<DOCNO>NCT00071240</DOCNO>
	<brief_summary>Growth hormone play important role development immune system . Studies suggest growth hormone may promote growth thymus , gland responsible production important immune cell call T cell . Since cell lose course HIV infection , possible growth hormone treatment could help restore immune system . This study determine whether administration growth hormone increase size function thymus cause increase number new T cell blood people infect HIV . Study hypothesis : Growth hormone treatment enhance T cell production HIV infect adult .</brief_summary>
	<brief_title>Growth Hormone Increase Immune Function People With HIV</brief_title>
	<detailed_description>The thymus major organ T cell production generally believe nonfunctional adult . Even nonfunctional , destroyed HIV infection T cell destroy peripheral lymphoid system . Given absence new T cell production pathologic acceleration T cell destruction , immune system collapse immunodeficiency ensues . However , study demonstrate thymic function adult HIV disease . Such function may induce positive feedback regulation T cell production presence absence function may play determinant role disease progression response highly active antiretroviral therapy ( HAART ) . These study suggest thymus functional many adult HIV disease thymic function might induce consequence HIV-mediated peripheral T cell depletion . Growth hormone potent regulator thymic function . This study determine whether true thymic function induce HIV infect adult , whether induction indeed prompt growth hormone , whether thymic function play role sustain T cell compartment face peripheral T cell depletion . Twenty-four volunteer enrol 2 year study . All participant receive 12 month treatment human growth hormone . Participants randomly assign one two study arm . Twelve participant ( Arm 1 ) receive growth hormone first year study ( 3 mg give daily subcutaneous injection , dose reduction 1.5 mg 6 month ) . Twelve participant ( Arm 2 ) enrol observational control arm ( placebo injection ) cross growth hormone treatment 1 year . Participants , whether Arm 1 Arm 2 , many 24 schedule study visit 2 year enrollment . In general , study visit occur every every 1 3 month . Study visit include physical exam , blood test , CT scan , PET scan , DEXA scan .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>HIV infect CD4 count 400 cells/mm3 less HIV viral load less 1000 copies/ml 1 year prior study entry ; case , viral load 5000 copies/ml acceptable Taking least 2 antiHIV medication Diabetes Cancer . Patients case Kaposi 's sarcoma skin cancer exclude . Some ( ) form heart disease Carpal Tunnel Syndrome Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Growth Hormone</keyword>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Thymus</keyword>
	<keyword>CD4 Cell</keyword>
	<keyword>Immune System</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>